Other bulletins in this series include:

Breast Surgery

Showing posts with label Ultraprotective ventilation. Show all posts
Showing posts with label Ultraprotective ventilation. Show all posts

Wednesday, 13 August 2025

 

Physiological and clinical effects of two ultraprotective ventilation strategies in patients with veno-venous extracorporeal membrane oxygenation: the ECMOVENT study

Annals of Intensive Care volume 15, Article number: 111, Published: 01 August 2025

Purpose

The optimal ventilation strategy in acute respiratory distress syndrome (ARDS) patients with veno-venous extracorporeal membrane oxygenation (VV-ECMO) remains unknown. We aimed to compare the effects of two ultra-protective ventilatory strategies applied to patients with ARDS and VV-ECMO.

Methods

Our study was an observational, retrospective, single-center study with a before-and-after design. All consecutive patients treated with VV-ECMO for severe ARDS between 2016 and 2023 were included. Before 2021, patients received a quasi-apneic ventilation strategy in assist-controlled volume mode with a tidal volume (VT) of 1 ml.kg−1 predicted body weight (PBW), a respiratory rate (RR) of 5 min−1 and a PEEP set to keep plateau pressure (PPLAT) between 20 and 25 cmH2O. From 2021 onwards, the protocolized ventilatory strategy consisted in pressure-controlled mode with a PEEP of 14 cmH2O, a driving pressure (∆P) of 8 cmH2O and a RR of 10 min−1. We evaluated the impact of strategies on longitudinal respiratory mechanics and on the time to successful ECMO weaning at day-90 after VV-ECMO canulation.

Results

121 patients were enrolled, with 69 receiving the VT1 strategy, and 52 the ∆P8 strategy. Over the first 7 days of ECMO, the ∆P8 strategy was associated with significantly higher ∆P and RR, lower PaCO2, and higher static elastic mechanical power, compared with the VT1 strategy. The day-90 survival rate was 30% with the VT1 strategy, and 42% with the ∆P8 strategy (P=0.19). Time to successful VV-ECMO weaning was 7 [413] days in day-90 survivors, with no significant difference between groups. The adjusted subdistribution hazard ratio associated with the P8 strategy was 0.99 (95% confidence interval: 0.531.84), as compared to the VT1 strategy (P>0.9).

Conclusions

In the context of our center, a ventilatory strategy targeting a PEEP of 14 cmH2O, a ∆P of 8 cmH2O and a RR of 10 min−1 led to the application of ∆P, RR and static elastic mechanical power and improved decarboxylation, compared to a strategy in volumetric mode with a VT of 1 ml.kg−1 PBW and a RR of 5 min−1, in patients with ARDS and VV-ECMO. No significant difference on clinical outcomes was observed between both strategies.